617 - Fecal Microbiota Transplantation in Irritable Bowel Syndrome with Predominant Abdominal Bloating: Results from a Double Blind, Placebo-Controlled Clinical Trial

Gastroenterology ◽

10.1016/s0016-5085(18)30860-6 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-130 ◽

Author(s):

Tom Holvoet ◽

Marie Joossens ◽

Boelens Jerina ◽

Evelien Christiaens ◽

Lander Heyerick ◽

...

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Fecal Microbiota Transplantation ◽

Fecal Microbiota ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Abdominal Bloating ◽

Irritable Bowel

Download Full-text

Therapeutic Effect of Chang’an I Recipe (肠安 I 号方) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial

Chinese Journal of Integrative Medicine ◽

10.1007/s11655-016-2596-9 ◽

2016 ◽

Vol 24 (9) ◽

pp. 645-652 ◽

Author(s):

Xu-dong Tang ◽

Bin Lu ◽

Zhen-hua Li ◽

Wei Wei ◽

Li-na Meng ◽

...

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Therapeutic Effect ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial.

Gut ◽

10.1136/gut.31.3.355 ◽

1990 ◽

Vol 31 (3) ◽

pp. 355-358 ◽

Author(s):

G Dobrilla ◽

B P Imbimbo ◽

L Piazzi ◽

G Bensi

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Longterm Treatment ◽

Cimetropium Bromide ◽

Irritable Bowel

Download Full-text

Phytotherapy in irritable bowel syndrome: a randomised double blind, placebo-controlled clinical trial

Focus on Alternative and Complementary Therapies ◽

10.1111/j.2042-7166.1997.tb00707.x ◽

2010 ◽

Vol 2 (4) ◽

pp. 187-187

Author(s):

B Brinkhaus ◽

C Hentschel ◽

M Lindner ◽

G Schindler ◽

J Bauer ◽

...

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Effects of Vitamin D supplementation in patients with irritable bowel syndrome: A randomized, double-blind, placebo-controlled clinical trial

International Journal of Preventive Medicine ◽

10.4103/ijpvm.ijpvm_512_17 ◽

2019 ◽

Vol 10 (1) ◽

pp. 16

Author(s):

Azita Hekmatdoost ◽

Mahsa Jalili ◽

Homayoon Vahedi ◽

Hossein Poustchi

Keyword(s):

Clinical Trial ◽

Vitamin D ◽

Irritable Bowel Syndrome ◽

Vitamin D Supplementation ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

914 - Fecal Microbiota Transplantation Alters Gut Microbiota in Patients with Irritable Bowel Syndrome: Results from a Randomized, Double-Blind Placebo Controlled Study

Gastroenterology ◽

10.1016/s0016-5085(18)31016-3 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-181 ◽

Author(s):

Sofie Halkjær ◽

Alice Christensen ◽

Bobby Lo ◽

Patrick Browne ◽

Stig Günther ◽

...

Keyword(s):

Irritable Bowel Syndrome ◽

Gut Microbiota ◽

Fecal Microbiota Transplantation ◽

Fecal Microbiota ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(20)30056-x ◽

2020 ◽

Vol 5 (7) ◽

pp. 658-666 ◽

Author(s):

Viola Andresen ◽

Jürgen Gschossmann ◽

Peter Layer

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Bifidobacterium Bifidum ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.723005598.793516772 ◽

2016 ◽

Author(s):

Robin Spiller

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Japanese Patients ◽

Controlled Clinical Trial ◽

The Novel ◽

Double Blind ◽

Male And Female ◽

Double Blind Placebo ◽

Irritable Bowel ◽

Download Full-text

Phytotherapy in irritable bowel syndrome: a randomised double blind, placebo-controlled clinical trial

Focus on Alternative and Complementary Therapies ◽

10.1111/j.2042-7166.1998.tb00914.x ◽

2010 ◽

Vol 3 (4) ◽

pp. 182-183

Author(s):

B Brinkhaus ◽

C Hentschel ◽

M Lindner ◽

G Schindler ◽

J Bauer ◽

...

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

Scandinavian Journal of Gastroenterology ◽

10.1080/00365520802240255 ◽

2008 ◽

Vol 43 (10) ◽

pp. 1202-1211 ◽

Author(s):

Kei Matsueda ◽

Shigeru Harasawa ◽

Michio Hongo ◽

Nobuo Hiwatashi ◽

Daisuke Sasaki

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Japanese Patients ◽

Controlled Clinical Trial ◽

The Novel ◽

Double Blind ◽

Male And Female ◽

Double Blind Placebo ◽

Irritable Bowel ◽

Download Full-text

Identification of Patients with Non-D, Non-C Irritable Bowel Syndrome and Treatment with Renzapride: An Exploratory, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Digestive Diseases and Sciences ◽

10.1007/s10620-008-0295-x ◽

2008 ◽

Vol 53 (12) ◽

pp. 3191-3200 ◽

Author(s):

R. C. Spiller ◽

N. L. Meyers ◽

R. I. Hickling

Keyword(s):

Clinical Trial ◽

Irritable Bowel Syndrome ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text